...
【24h】

Meta-analysis of second-trimester markers for trisomy 21.

机译:对21三体妊娠中期妊娠标记的Meta分析。

获取原文
获取原文并翻译 | 示例
           

摘要

To summarize by meta-analysis the accumulated data on the screening performance of second-trimester sonographic markers for fetal trisomy?21.We conducted a literature search to identify studies between 1995 and September 2012 that provided data on the incidence of sonographic markers in trisomy 21 and euploid fetuses at 14-24 weeks' gestation. Weighted independent estimates of detection rate, false-positive rate and positive and negative likelihood ratios (LR) of markers were calculated.A total of 48 studies was included in the analysis. The pooled estimates of positive and negative LR were, respectively: 5.83 (95% CI, 5.02-6.77) and 0.80 (95% CI, 0.75-0.86) for intracardiac echogenic focus; 27.52 (95% CI, 13.61-55.68) and 0.94 (95% CI, 0.91-0.98) for ventriculomegaly; 23.30 (95% CI, 14.35-37.83) and 0.80 (95% CI, 0.74-0.85) for increased nuchal fold; 11.44 (95% CI, 9.05-14.47) and 0.90 (95% CI, 0.86-0.94) for hyperechogenic bowel; 7.63 (95% CI, 6.11-9.51) and 0.92 (95% CI, 0.89-0.96) for mild hydronephrosis; 3.72 (95% CI, 2.79-4.97) and 0.80 (95% CI, 0.73-0.88) for short femur; 4.81 (95% CI, 3.49-6.62) and 0.74 (95% CI, 0.63-0.88) for short humerus; 21.48 (95% CI, 11.48-40.19) and 0.71 (95% CI, 0.57-0.88) for aberrant right subclavian artery (ARSA); and 23.27 (95% CI, 14.23-38.06) and 0.46 (95% CI, 0.36-0.58) for absent or hypoplastic nasal bone. The combined negative LR, obtained by multiplying the values of individual markers, was 0.13 (95% CI, 0.05-0.29) when short femur but not short humerus was included and 0.12 (95% CI, 0.06-0.29) when short humerus but not short femur was included.The presence of sonographic markers increases, and absence of such markers decreases, the risk for trisomy 21. In the case of most isolated markers there is only a small effect on modifying the pre-test odds for trisomy 21, but with ventriculomegaly, nuchal fold thickness and ARSA there is a 3-4-fold increase in risk and with hypoplastic nasal bone a 6-7-fold increase. Copyright ? 2012 ISUOG. Published by John Wiley & Sons, Ltd.
机译:通过荟萃分析总结了胎儿三体性妊娠中期妊娠超声检查标志物筛查性能的累积数据21.我们进行了文献检索,以鉴定1995年至2012年9月之间的研究,这些研究提供了21三体性超声检查标志物发生率的数据。和整倍体胎儿在怀孕14-24周。计算标记物的检出率,假阳性率以及阳性和阴性似然比(LR)的加权独立估计值。该分析共包括48个研究。阳性和阴性LR的合并估计分别为:心脏内回声聚焦的5.83(95%CI,5.02-6.77)和0.80(95%CI,0.75-0.86);脑室扩大为27.52(95%CI,13.61-55.68)和0.94(95%CI,0.91-0.98);颈部褶皱增加的23.30(95%CI,14.35-37.83)和0.80(95%CI,0.74-0.85);高回肠的肠为11.44(95%CI,9.05-14.47)和0.90(95%CI,0.86-0.94);轻度肾盂积水7.63(95%CI,6.11-9.51)和0.92(95%CI,0.89-0.96);股骨短时为3.72(95%CI,2.79-4.97)和0.80(95%CI,0.73-0.88);短肱骨为4.81(95%CI,3.49-6.62)和0.74(95%CI,0.63-0.88);右锁骨下动脉异常(ARSA)为21.48(95%CI,11.48-40.19)和0.71(95%CI,0.57-0.88);鼻骨缺失或增生的分别为23.27(95%CI,14.23-38.06)和0.46(95%CI,0.36-0.58)。通过将各个标记物的值相乘获得的组合负LR在包括短股骨但不包括短肱骨时为0.13(95%CI,0.05-0.29),而当包括短肱骨但不包括肱骨时为0.12(95%CI,0.06-0.29)超声标记物的存在会增加,而这些标记物的缺失会减少21号三体症的风险。对于大多数分离的标志物,对改变21号三体症的检测前几率只有很小的影响,但是心室肥大,颈部折叠厚度增加和ARSA风险增加3-4倍,鼻骨发育不良患者增加6-7倍。版权? 2012年ISUOG。由John Wiley&Sons,Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号